Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Immuno-Oncology Congress 2022

GI tumours

Signals and rational development opportunities for immunotherapy in MMR proficient colorectal cancer

Date

09 Dec 2022

Session

GI tumours

Topics

Clinical Research;  Translational Research;  Immunotherapy

Tumour Site

Colon and Rectal Cancer

Presenters

Marco Gerlinger

Authors

M. Gerlinger

Author affiliations

  • ICR - Institute of Cancer Research, London/GB

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A

Presenter: Marco Gerlinger

Session: GI tumours

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.